Osteopontin Expression Is Associated with the Poor Prognosis in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy.
Tai-Jan ChiuHung-I LuChang-Han ChenWan-Ting HuangYu-Ming WangWei-Che LinShau-Hsuan LiPublished in: BioMed research international (2018)
Our results suggest that osteopontin may be a potential therapeutic target for patients with ESCC treated with preoperative chemoradiotherapy.